Provided by Tiger Trade Technology Pte. Ltd.

Hutchison China Meditech

12.38
-0.0350-0.28%
Post-market: 12.31-0.0700-0.57%19:30 EDT
Volume:59.14K
Turnover:733.41K
Market Cap:2.16B
PE:122.63
High:12.48
Open:12.40
Low:12.34
Close:12.42
52wk High:18.30
52wk Low:9.77
Shares:174.43M
Float Shares:104.00M
Volume Ratio:0.85
T/O Rate:0.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.1010
EPS(LYR):2.60
ROE:1.46%
ROA:-1.24%
PB:1.71
PE(LYR):4.76

Loading ...

Tenaya Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference

GlobeNewswire
·
Aug 05

UOB Kay Hian Remains a Buy on HUTCHMED (China) (HCM)

TIPRANKS
·
Aug 04

UBS Adjusts HUTCHMED Target Price to HK$29.5, Maintains Buy Rating

Stock News
·
Aug 03

Huatai Securities Sticks to Their Buy Rating for HUTCHMED (China) (HCM)

TIPRANKS
·
Aug 01

Hutchmed H1 Earnings Fall, Revenue Rises

MT Newswires Live
·
Jul 30

Lexicon Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 6, 2026

GlobeNewswire
·
Jul 30

Lexicon Pharmaceuticals: Advancing Cardiometabolic Pipeline and Phase 3 HCM Data Support Unchanged $6 Price Target and Buy Rating

TIPRANKS
·
Jul 27

Lexicon completes enrollment in SONATA-HCM study

TIPRANKS
·
Jul 27

Earning Preview: Hutchison China Meditech revenue seen stabilizing, and institutional views are bullish

Earnings Agent
·
Jul 24

Does Paycom’s New HCM-Embedded Asset Management Tool Deepen Its Automation Edge for Investors (PAYC)?

Simply Wall St.
·
Jul 22

Hutchmed’s HMPL‑760 Phase III Lymphoma Trial Moves Forward, Raising Long‑Term Stakes for HCM Investors

TIPRANKS
·
Jul 21

Asure Software to Announce Second Quarter 2026 Financial Results on July 30, 2026

GlobeNewswire
·
Jul 17

Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire
·
Jul 15

Hutchmed (china) is Maintained at Buy by B of a Securities

Dow Jones
·
Jul 07

Hutchmed price target lowered to $17 from $20 at BofA

TIPRANKS
·
Jul 07

Cytokinetics Announces Three Late-Breaking Science Abstracts at the European Society of Cardiology (ESC) Congress 2026

GlobeNewswire
·
Jul 07

HUTCHMED (China) (HCM) Gets a Buy from UBS

TIPRANKS
·
Jul 04

Hutchmed announces China NMPA approval for Orpathys NDA

TIPRANKS
·
Jul 02

HUTCHMED's Savolitinib Gains Conditional NMPA Approval for MET-Amplified Gastric Cancer

Stock News
·
Jul 02

Press Release: Tenaya Therapeutics Appoints Eric Hyllengren as Chief Financial Officer

Dow Jones
·
Jun 29